A question for you StanJupiter, in the aGVHD trials from memory there was only a few days between steroids use and REM-l application.
In the new Ulcerative colitis trial they are fully flushing previous steroids.
Are you suggesting that REM-l would be a first line treatment for aGVHD?
Reg
Ann: Mesoblast Update on COVID-19 ARDS Trial, page-966
-
- There are more pages in this discussion • 110 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.40 |
Change
0.005(0.36%) |
Mkt cap ! $1.592B | |||
| Open | High | Low | Value | Volume |
| $1.41 | $1.43 | $1.40 | $812.0K | 576.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 6688 | $1.40 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.40 | 9255 | 1 |
View Market Depth
| Last trade - 10.22am 11/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |